As of 2025-06-04, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 48.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -73.4%.
The range of the Relative Valuation is 30.73 - 65.08 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.9x - 21.2x | 18.5x |
| Forward P/E multiples | 11.8x - 21.0x | 15.6x |
| Fair Price | 30.73 - 65.08 | 48.62 |
| Upside | -83.2% - -64.3% | -73.4% |
| Date | P/E |